Undag, Jenelyn B.
HRN: 24-11-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/16/2024
07/23/2024
IV
500mg
Q8h
AGE With Moderate Dehydration Sec To Amoebiasis; Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes